Lifestance HealthLFST
LFST
About: LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
Employees: 10,218
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
474% more call options, than puts
Call options by funds: $44.7M | Put options by funds: $7.77M
171% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 14
79% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 34
18% more funds holding
Funds holding: 130 [Q3] → 153 (+23) [Q4]
8% more capital invested
Capital invested by funds: $2.3B [Q3] → $2.48B (+$178M) [Q4]
1.99% more ownership
Funds ownership: 85.98% [Q3] → 87.98% (+1.99%) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$8
22%
upside
Avg. target
$8.50
29%
upside
High target
$9
37%
upside
2 analyst ratings
2 positive
100%
0 neutral
0%
0 negative
0%
Keybanc Steve Dechert 0% 1-year accuracy 0 / 1 met price target | 37%upside $9 | Overweight Initiated | 8 Apr 2025 |
Canaccord Genuity Richard Close 29% 1-year accuracy 7 / 24 met price target | 22%upside $8 | Buy Initiated | 3 Apr 2025 |
Financial journalist opinion
Based on 4 articles about LFST published over the past 30 days
Negative
Zacks Investment Research
17 hours ago
LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Positive
Seeking Alpha
1 week ago
LifeStance Health Group: Solid Execution Drives Growth And Margin Expansion
I remain bullish on LifeStance Health Group stock due to robust demand, clinician retention, and margin expansion potential, despite recent share price declines. LFST's flexible hybrid care model and digital check-in tool enhance clinician retention and patient accessibility, driving sustainable growth and competitive advantage. LFST's adjusted EBITDA margin reached 10.1% in 4Q24, with management targeting 15-20% over time, supported by operational efficiencies and higher-margin services.
Neutral
GlobeNewsWire
1 week ago
LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025
SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025.
Positive
Zacks Investment Research
2 weeks ago
LifeStance Health (LFST) Surges 5.8%: Is This an Indication of Further Gains?
LifeStance Health (LFST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Negative
Zacks Investment Research
1 month ago
LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Neutral
Seeking Alpha
2 months ago
LifeStance Health Group, Inc. (LFST) Q4 2024 Earnings Call Transcript
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ken Burdick - CEO David Bourdon - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Andrea Alfonso - UBS Operator Thank you for standing by. My name is Danielle, and I will be your conference operator today.
Negative
Zacks Investment Research
2 months ago
LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates
LifeStance Health Group (LFST) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.12 per share a year ago.
Neutral
PRNewsWire
2 months ago
LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman
Ryan McGroarty to Become Chief Financial Officer SCOTTSDALE, Ariz. , Feb. 27, 2025 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (Nasdaq: LFST), one of the nation's largest providers of outpatient mental health care, today announced that its Board of Directors has appointed Dave Bourdon as the Company's new Chief Executive Officer.
Neutral
GlobeNewsWire
2 months ago
LifeStance Reports Fourth Quarter and Full Year 2024 Results
SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2024.
Negative
Zacks Investment Research
2 months ago
LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Charts implemented using Lightweight Charts™